Dark

AMGN
Amgen Inc
stock NASDAQ

At Close

Oct 2, 2026 3:59:53 PM EDT

402.95USD-1.061%(-4.32)3,510,313

0.00Bid 0.00Ask 0.00Spread

Pre-market

Oct 2, 2026 9:28:30 AM EDT

410.21USD+0.722%(+2.94)1,076

After-hours

Oct 2, 2026 4:39:30 PM EDT

403.04USD+0.022%(+0.09)47,314

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

217.81B

CEO

Robert Bradway

Headquarters

Thousand Oaks, California, USA

Industry

Drug Manufacturers-General

Next Earnings

Nov 3, 2026 (30d)

Last Dividend

Aug 21, 20262.520

Last Split

Nov 22, 19992for1

ALXN CELG GILD BIIB GSK BMY JNJ PFE ABBV XLV

AMGN Stats

Avg. Vol. 10 Day

2,997,026

Avg. Vol. 30 Day

2,929,298

Employees

20,800

Market Cap

217,809,822,174

Shares Out.

540,632,005

On/Off Exchange

56%/44%

6 Month Beta

0.41

1 Year Beta

0.50

2 Year Beta

0.44

3 Year Beta

0.51

52 Week Low

288.00

52 Week High

447.03

SMA50

409.48

SMA200

364.54

1 Week

-3.65%

1 Month

-7.86%

3 Month

+9.94%

6 Month

+17.61%

1 Year

+35.25%

2 Year

+26.03%

5 Year

+90.54%

Profile

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.

AMGN Stock Summary

Amgen Inc (NASDAQ:AMGN) stock price today is $402.95, and today's volume is 3,510,313. AMGN is down -1.061% today. The 30 day average volume is 2,929,298. AMGN market cap is 217.81B with 540,632,005 shares outstanding.

document.getElementById("ZLPMnB").onerror = function(){this.style.display='none';}; .dark-mode .frXzv4{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .frXzv4{ color: #333333; background-color: white; border: 2px solid #333333; }AMGNAmgen Incstock NASDAQ

AMGN Stock Summary

AMGN
Amgen Inc
stock NASDAQ